Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Intesity Therapeutics Inc INTS

Healthcare Biotechnology
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical... see more

Current News (NDAQ:INTS)

Intensity Therapeutics, Inc. to Present Two Posters at the 2025 San Antonio Breast Cancer Symposium

PR Newswire December 11, 2025

Intensity Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement

PR Newswire December 5, 2025

Intensity Therapeutics Announces Two Presentations at the Upcoming 2025 San Antonio Breast Cancer Symposium

PR Newswire December 4, 2025

Intensity Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

PR Newswire November 6, 2025

Intensity Therapeutics, Inc. Announces Pricing of $4 Million Registered Direct Offering of Common Stock

PR Newswire October 31, 2025

Intensity Therapeutics, Inc. Announces Publication of Clinical Results of INT230-6 for the Treatment of Metastatic or Refractory Cancers in eBioMedicine, a Lancet Discovery Science Journal

PR Newswire October 30, 2025

Intensity Therapeutics Reports INVINCIBLE-4, Presurgical Triple-Negative Breast Cancer Study Update

PR Newswire September 10, 2025

Intensity Therapeutics, Inc. to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference

PR Newswire September 2, 2025

Intensity Therapeutics, Inc. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement

PR Newswire August 12, 2025
View More News ››

Opinion & Analysis (NDAQ:INTS)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:INTS)

RE:RE:INTS....ur all being led to the Slaughter house

Just keep "averaging down".......u might get lucky and catch the bottom.....Maybe ; ) Now trading at 74 f'king cents...
Iseneschal - October 31, 2025

RE:INTS....ur all being led to the Slaughter house

Worth a repeat ?? Now trading at $0.98 on 50.5 million shares It's going to get worse....drink some more Kool-Aide ; )
Iseneschal - October 31, 2025

INTS....next support at $0.81

$1.01 now
Iseneschal - October 30, 2025

INTS ....back from halt and in total PB mode

$1.09 now
Iseneschal - October 30, 2025

INTS....ur all being led to the Slaughter house

$1.24 right now
Iseneschal - October 30, 2025

INTS....don't Drink the Kool-Aide

You'll be sorry !!!!!!
Iseneschal - October 30, 2025
View more Bullboard ››

AKITA Drilling Ltd.

AKITA Drilling Ltd.

AKITA Drilling Ltd. operates as an oil and gas drilling contractor in Canada and the United States. It is involved in the ...
View More »

Podcasts